Knowledge Center

Patent / Aug 04, 2022

Inhaled ivermectin

Authors:
  • Beatriz Fernandes
  • João Henriques
  • Eunice Costa
  • Venkatesh Naini
Source:
US 20220241307

The present invention contemplates the use of inhaled ivermectin for use in various viruses and parasitic infections (treatment and/or prophylaxis) that are present or manifest in the lungs or respiratory tract. Exemplary dosing, formulations, devices, and processing techniques are also disclosed herein.
Ìý

Also in the Knowledge Center

Related Content

Macau 10th November

Gallery of photos - the best moments of the event

Page
Read more

¶Ù¾±²õ±è±ð°ù²õ´Ç³¾±ð®

Make your drug soluble with ¶Ù¾±²õ±è±ð°ù²õ´Ç³¾±ð® technology. ¶Ù¾±²õ±è±ð°ù²õ´Ç³¾±ð® is a solubility enhancement technology that relies on an innovative and naturally occurring excipient to develop amorphous solid dispersions with high drug loading and high bioavailability.

Page
Read more

Global Sales and Marketing Meeting - GSM 2023

Hi there! Find here the relevant information about the Global Sales, Marketing & Communications and PMO Meeting in Lisbon, Portugal.

Page
Read more